Daubert v. Merrell Dow Pharmaceuticals, Inc.
Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), is a United States Supreme Court case determining the standard for admitting expert testimony in federal courts. In Daubert, the Court held that the enactment of the Federal Rules of Evidence implicitly overturned the Frye standard; the standard that the Court articulated is referred to as the Daubert standard.
| Daubert v. Merrell Dow Pharmaceuticals | |
|---|---|
Supreme Court of the United States | |
| Argued March 30, 1993 Decided June 28, 1993 | |
| Full case name | William Daubert, et ux., etc., et al., Petitioners v. Merrell Dow Pharmaceuticals, Inc. |
| Docket no. | 92-102 |
| Citations | 509 U.S. 579 (more) |
| Case history | |
| Prior | Summary judgment granted to defendants, 727 F.Supp. 570 (S.D. Cal. 1989); affirmed, 951 F.2d 1128 (9th Cir. 1991); certiorari granted, 506 U.S. 914 (1992) |
| Holding | |
| The Federal Rules of Evidence govern the admission of scientific evidence in a trial held in federal court. They require the trial judge to act as a gatekeeper before admitting the evidence, determining that the evidence is scientifically valid and relevant to the case at hand. | |
| Court membership | |
| |
| Case opinions | |
| Majority | Blackmun, joined by White, O'Connor, Scalia, Kennedy, Souter, Thomas |
| Concur/dissent | Rehnquist, joined by Stevens |
| Laws applied | |
| Federal Rules of Evidence 104(a), 702, 703 | |
This case overturned a previous ruling or rulings | |
| Frye v. United States (1923) | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.